Be-All End-All Real-World Evidence on the Subcutaneous ICD
- 5 January 2021
- journal article
- editorial
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 143 (1), 18-20
- https://doi.org/10.1161/circulationaha.120.050861
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extractionHeart Rhythm, 2017
- Implant and Midterm Outcomes of the Subcutaneous Implantable Cardioverter-Defibrillator RegistryJournal of the American College of Cardiology, 2017
- DefibrillatorsCirculation, 2016
- Safety and Efficacy of the Totally Subcutaneous Implantable DefibrillatorJournal of the American College of Cardiology, 2015
- Effect of Long-Detection Interval vs Standard-Detection Interval for Implantable Cardioverter-Defibrillators on Antitachycardia Pacing and Shock DeliveryJAMA, 2013
- Reduction in Inappropriate Therapy and Mortality through ICD ProgrammingThe New England Journal of Medicine, 2012
- An Entirely Subcutaneous Implantable Cardioverter–DefibrillatorThe New England Journal of Medicine, 2010
- Risk Factors for Implantable Defibrillator Lead Fracture in a Recalled and a Nonrecalled LeadJournal of Cardiovascular Electrophysiology, 2010
- Termination of Malignant Ventricular Arrhythmias with an Implanted Automatic Defibrillator in Human BeingsThe New England Journal of Medicine, 1980